Sedana Medical AB (publ)
STO:SEDANA

Watchlist Manager
Sedana Medical AB (publ) Logo
Sedana Medical AB (publ)
STO:SEDANA
Watchlist
Price: 10.58 SEK 0.38% Market Closed
Market Cap: 1.1B SEK

Sedana Medical AB (publ)
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sedana Medical AB (publ)
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sedana Medical AB (publ)
STO:SEDANA
Revenue
kr197.6m
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Revenue
kr17.6B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Revenue
kr975m
CAGR 3-Years
9%
CAGR 5-Years
56%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Revenue
kr748.5m
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
12%
Getinge AB
STO:GETI B
Revenue
kr34.8B
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Revenue
kr11.3B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

Sedana Medical AB (publ)
Glance View

Market Cap
1.1B SEK
Industry
Health Care

Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.

SEDANA Intrinsic Value
24.78 SEK
Undervaluation 57%
Intrinsic Value
Price

See Also

What is Sedana Medical AB (publ)'s Revenue?
Revenue
197.6m SEK

Based on the financial report for Sep 30, 2025, Sedana Medical AB (publ)'s Revenue amounts to 197.6m SEK.

What is Sedana Medical AB (publ)'s Revenue growth rate?
Revenue CAGR 5Y
11%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Sedana Medical AB (publ) have been 14% over the past three years , 11% over the past five years .

Back to Top